Federation Des Caisses Desjardins Du Quebec Evofem Biosciences, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 14, 2024
SELL
$0.17 - $1.35 $5 - $41
-31 Closed
0 $0
Q2 2022

Aug 14, 2024
BUY
$0.29 - $4.46 $8 - $138
31 New
31 $35,000

About Evofem Biosciences, Inc.

EVFM Quotes by TradingView
  • Ticker EVFM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,459,200
  • Market Cap $855K
  • Description
  • Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prev...
More about EVFM
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email